| | | | | | | | | | | | | | | | |
| | |
 | Issue Date FY: 2025 ( Subtotal = $0 ) |
| | 2025 | 2022 | GAIA MEDICAL INSTITUTE, INC. | 505 COAST BLVD S STE 104 | LA JOLLA | CA | 92037-4614 | SAN DIEGO | USA | R44HD097039 | Rapid saliva test for diagnosis of mTBI and prognosis of Persistent Post-conccussion Symptoms (PPCS) in children and adults | 000 | 3 | NIH | 1/16/2025 | $0 |
|
| Issue Date FY: 2023 ( Subtotal = $1,302,154 ) |
| | 2023 | 2023 | GAIA MEDICAL INSTITUTE, LLC, THE | 505 COAST BLVD S | LA JOLLA | CA | 92037-4614 | SAN DIEGO | USA | R44AG078044 | Rapid saliva test for noninvasive diagnostic screening of MCI and dementia | 000 | 2 | NIH | 7/25/2023 | $1,302,154 |
|
| Issue Date FY: 2022 ( Subtotal = $2,114,911 ) |
| | 2022 | 2022 | GAIA MEDICAL INSTITUTE, LLC, THE | 505 COAST BLVD SOUTH, STE 104 | LA JOLLA | CA | 92037-4614 | SAN DIEGO | USA | R44AG078044 | Rapid saliva test for noninvasive diagnostic screening of MCI and dementia | 001 | 1 | NIH | 8/15/2022 | $0 |
| | 2022 | 2022 | GAIA MEDICAL INSTITUTE, LLC, THE | 505 COAST BLVD SOUTH, STE 104 | LA JOLLA | CA | 92037-4614 | SAN DIEGO | USA | R44HD097039 | Rapid saliva test for diagnosis of mTBI and prognosis of Persistent Post-conccussion Symptoms (PPCS) in children and adults | 001 | 3 | NIH | 9/8/2022 | $832,833 |
| | 2022 | 2022 | GAIA MEDICAL INSTITUTE, LLC, THE | 505 COAST BLVD SOUTH, STE 104 | LA JOLLA | CA | 92037-4614 | SAN DIEGO | USA | R44AG078044 | Rapid saliva test for noninvasive diagnostic screening of MCI and dementia | 000 | 1 | NIH | 6/23/2022 | $1,282,078 |
| | 2022 | 2021 | GAIA MEDICAL INSTITUTE, LLC, THE | 505 COAST BLVD SOUTH, STE 104 | LA JOLLA | CA | 92037-4614 | SAN DIEGO | USA | R44HD097039 | Rapid saliva test for diagnosis of mTBI and prognosis of Persistent Post-conccussion Symptoms (PPCS) in children and adults | 000 | 2 | NIH | 2/2/2022 | $0 |
| | 2022 | 2018 | GAIA MEDICAL INSTITUTE, LLC, THE | 505 COAST BLVD SOUTH, STE 104 | LA JOLLA | CA | 92037-4614 | SAN DIEGO | USA | R43HD097039 | Saliva biomarkers for noninvasive diagnostics of acute mTBI in children | 000 | 1 | NIH | 5/10/2022 | $0 |
| | 2022 | 2018 | GAIA MEDICAL INSTITUTE, LLC, THE | 505 COAST BLVD SOUTH, STE 104 | LA JOLLA | CA | 92037-4614 | SAN DIEGO | USA | R44HD090817 | Rapid saliva test for diagnostics of Neuro-Cognitive Disorder due to Traumatic Brain Injury (NCDT) | 000 | 2 | NIH | 10/28/2021 | $0 |
|
| Issue Date FY: 2021 ( Subtotal = $865,950 ) |
| | 2021 | 2021 | GAIA MEDICAL INSTITUTE, LLC, THE | 505 COAST BLVD SOUTH, STE 104 | LA JOLLA | CA | 92037-4614 | SAN DIEGO | USA | R44HD097039 | Rapid saliva test for diagnosis of mTBI and prognosis of Persistent Post-conccussion Symptoms (PPCS) in children and adults | 000 | 2 | NIH | 9/17/2021 | $865,950 |
| | 2021 | 2018 | GAIA MEDICAL INSTITUTE, LLC, THE | 505 COAST BLVD SOUTH, STE 104 | LA JOLLA | CA | 92037-4614 | SAN DIEGO | USA | R43CE003070 | Saliva biomarkers for predicting outcome in pediatric and adult patients with severe and moderate TBI | 04 | 1 | CDC | 1/21/2021 | $0 |
|
| Issue Date FY: 2020 ( Subtotal = $54,300 ) |
| | 2020 | 2020 | GAIA MEDICAL INSTITUTE, LLC, THE | 505 COAST BLVD SOUTH, STE 104 | LA JOLLA | CA | 92037-4614 | SAN DIEGO | USA | R43HD097039 | Saliva biomarkers for noninvasive diagnostics of acute mTBI in children | 003 | 1 | NIH | 7/30/2020 | $0 |
| | 2020 | 2020 | GAIA MEDICAL INSTITUTE, LLC, THE | 505 COAST BLVD SOUTH, STE 104 | LA JOLLA | CA | 92037-4614 | SAN DIEGO | USA | R43HD097039 | Saliva biomarkers for noninvasive diagnostics of acute mTBI in children | 000 | 1 | NIH | 2/3/2020 | $54,300 |
| | 2020 | 2020 | GAIA MEDICAL INSTITUTE, LLC, THE | 505 COAST BLVD SOUTH, STE 104 | LA JOLLA | CA | 92037-4614 | SAN DIEGO | USA | R43HD097039 | Saliva biomarkers for noninvasive diagnostics of acute mTBI in children | 001 | 1 | NIH | 4/8/2020 | $0 |
| | 2020 | 2018 | GAIA MEDICAL INSTITUTE, LLC, THE | 505 COAST BLVD SOUTH, STE 104 | LA JOLLA | CA | 92037-4614 | SAN DIEGO | USA | R43HD097039 | Saliva biomarkers for noninvasive diagnostics of acute mTBI in children | 002 | 1 | NIH | 7/30/2020 | $0 |
| | 2020 | 2018 | GAIA MEDICAL INSTITUTE, LLC, THE | 505 COAST BLVD SOUTH, STE 104 | LA JOLLA | CA | 92037-4614 | SAN DIEGO | USA | R44HD090817 | Rapid saliva test for diagnostics of Neuro-Cognitive Disorder due to Traumatic Brain Injury (NCDT) | 000 | 2 | NIH | 7/29/2020 | $0 |
| | 2020 | 2017 | GAIA MEDICAL INSTITUTE, LLC, THE | 505 COAST BLVD SOUTH, STE 104 | LA JOLLA | CA | 92037-4614 | SAN DIEGO | USA | R44DE021672 | NEXT-GEN Oral test for monitoring HIV/AIDS in Point-of-Care | 000 | 3 | NIH | 5/3/2020 | $0 |
|
| Issue Date FY: 2019 ( Subtotal = $0 ) |
| | 2019 | 2018 | GAIA MEDICAL INSTITUTE, LLC, THE | 505 COAST BLVD SOUTH, STE 104 | LA JOLLA | CA | 92037-4614 | SAN DIEGO | USA | R43HD097039 | Saliva biomarkers for noninvasive diagnostics of acute mTBI in children | 001 | 1 | NIH | 11/8/2018 | $0 |
| | 2019 | 2018 | GAIA MEDICAL INSTITUTE, LLC, THE | 505 COAST BLVD SOUTH, STE 104 | LA JOLLA | CA | 92037-4614 | SAN DIEGO | USA | R43CE003070 | Saliva biomarkers for predicting outcome in pediatric and adult patients with severe and moderate TBI | 01 | 1 | CDC | 11/21/2018 | $0 |
| | 2019 | 2018 | GAIA MEDICAL INSTITUTE, LLC, THE | 505 COAST BLVD SOUTH, STE 104 | LA JOLLA | CA | 92037-4614 | SAN DIEGO | USA | R43HD097039 | Saliva biomarkers for noninvasive diagnostics of acute mTBI in children | 000 | 1 | NIH | 11/6/2018 | $0 |
| | 2019 | 2018 | GAIA MEDICAL INSTITUTE, LLC, THE | 505 COAST BLVD SOUTH, STE 104 | LA JOLLA | CA | 92037-4614 | SAN DIEGO | USA | R43CE003070 | Saliva biomarkers for predicting outcome in pediatric and adult patients with severe and moderate TBI | 03 | 1 | CDC | 7/24/2019 | $0 |
| | 2019 | 2018 | GAIA MEDICAL INSTITUTE, LLC, THE | 505 COAST BLVD SOUTH, STE 104 | LA JOLLA | CA | 92037-4614 | SAN DIEGO | USA | R43CE003070 | Saliva biomarkers for predicting outcome in pediatric and adult patients with severe and moderate TBI | 02 | 1 | CDC | 3/29/2019 | $0 |
|
| Issue Date FY: 2018 ( Subtotal = $1,423,347 ) |
| | 2018 | 2018 | GAIA MEDICAL INSTITUTE, LLC, THE | 505 COAST BLVD SOUTH, STE 104 | LA JOLLA | CA | 92037-4614 | SAN DIEGO | USA | R43HD097039 | Saliva biomarkers for noninvasive diagnostics of acute mTBI in children | 000 | 1 | NIH | 9/15/2018 | $298,862 |
| | 2018 | 2018 | GAIA MEDICAL INSTITUTE, LLC, THE | 505 COAST BLVD SOUTH, STE 104 | LA JOLLA | CA | 92037-4614 | SAN DIEGO | USA | R43CE003070 | Saliva biomarkers for predicting outcome in pediatric and adult patients with severe and moderate TBI | 00 | 1 | CDC | 9/19/2018 | $225,000 |
| | 2018 | 2018 | GAIA MEDICAL INSTITUTE, LLC, THE | 505 COAST BLVD SOUTH, STE 104 | LA JOLLA | CA | 92037-4614 | SAN DIEGO | USA | R44DE021672 | NEXT-GEN Oral test for monitoring HIV/AIDS in Point-of-Care | 000 | 3 | NIH | 9/11/2018 | $162,910 |
| | 2018 | 2018 | GAIA MEDICAL INSTITUTE, LLC, THE | 505 COAST BLVD SOUTH, STE 104 | LA JOLLA | CA | 92037-4614 | SAN DIEGO | USA | R44HD090817 | Rapid saliva test for diagnostics of Neuro-Cognitive Disorder due to Traumatic Brain Injury (NCDT) | 000 | 2 | NIH | 7/19/2018 | $736,575 |
|
| Issue Date FY: 2017 ( Subtotal = $1,082,357 ) |
| | 2017 | 2017 | GAIA MEDICAL INSTITUTE, LLC, THE | 505 COAST BLVD SOUTH, STE 104 | LA JOLLA | CA | 92037-4614 | SAN DIEGO | USA | R44HD090817 | Rapid saliva test for diagnostics of Neuro-Cognitive Disorder due to Traumatic Brain Injury (NCDT) | 000 | 1 | NIH | 8/11/2017 | $708,335 |
| | 2017 | 2017 | GAIA MEDICAL INSTITUTE, LLC, THE | 505 COAST BLVD SOUTH, STE 104 | LA JOLLA | CA | 92037-4614 | SAN DIEGO | USA | R44DE021672 | NEXT-GEN Oral test for monitoring HIV/AIDS in Point-of-Care | 000 | 3 | NIH | 8/18/2017 | $374,022 |
|
| Issue Date FY: 2016 ( Subtotal = $434,121 ) |
| | 2016 | 2016 | GAIA MEDICALINSTITUTE LLC | 12650 INTERMEZZO WAY | SAN DIEGO | CA | 92130 | SAN DIEGO | USA | R44DE021672 | NEXT-GEN Oral test for monitoring HIV/AIDS in Point-of-Care | 000 | 2 | NIH | 8/29/2016 | $434,121 |
|
| Issue Date FY: 2011 ( Subtotal = $442,248 ) |
| | 2011 | 2011 | GAIA MEDICALINSTITUTE LLC | 12650 INTERMEZZO WAY | SAN DIEGO | CA | 92130 | SAN DIEGO | USA | R43DE021672 | RAPID ORAL TEST FOR THERAPEUTIC RESPONSE IN HIV/AIDS PATIENTS | 000 | 1 | NIH | 8/15/2011 | $442,248 |
|
|
